Sexually Transmitted Diseases Diagnostics Market by Technology (Culture Methods, Microscopy, Nucleic Acid Amplification), Disease (Chlamydia, Gonorrhea, Herpes), End User, Distribution Channel, Test Type, Sample Type - Global Forecast 2025-2030- Product Image

Sale

Sexually Transmitted Diseases Diagnostics Market by Technology (Culture Methods, Microscopy, Nucleic Acid Amplification), Disease (Chlamydia, Gonorrhea, Herpes), End User, Distribution Channel, Test Type, Sample Type - Global Forecast 2025-2030

Report
195 Pages
August 2025
Region: Global
360iResearch™
ID: 6055581

UP TO €616EUR$697USD£532GBP OFF until Dec 31^st 2025

The sexually transmitted disease diagnostics market is evolving rapidly, driven by technology advancements and increased global focus on public health. Senior decision-makers seeking actionable market intelligence need clarity on the shifting landscape, innovation priorities, and key operational dynamics impacting this sector.

Market Snapshot: Sexually Transmitted Disease Diagnostics Market Overview

The sexually transmitted diseases diagnostics market grew from USD 12.78 billion in 2024 to USD 13.53 billion in 2025. It is projected to expand at a CAGR of 6.03%, aiming to reach USD 18.17 billion by 2030. Continuous innovation in molecular diagnostics, point-of-care technologies, and digital health integration support strong, sustained growth in this sector. This momentum is reinforced by evolving epidemiological trends, technological convergence, and a global imperative to address public health equity challenges.

Scope & Segmentation

This comprehensive report offers in-depth analysis and forecasting across extensive market segments and geographies. Key areas include:

Technology: Covers a spectrum of diagnostic approaches, including culture methods (bacterial and cell), microscopy (electron and light), nucleic acid amplification (such as loop-mediated isothermal amplification, PCR, transcription mediated amplification), rapid diagnostics (lateral flow assays, microfluidic devices), and serological assays (enzyme-linked immunosorbent assays, rapid immunoassays).
Disease Focus: Encompasses the full range of infections, including Chlamydia, Gonorrhea, Herpes, HIV, Human Papillomavirus, and Syphilis, with tailored diagnostic protocols for each condition.
End User: Details adoption patterns within clinics, diagnostic laboratories, hospitals, and research institutes, each with distinct operational priorities and regulatory environments.
Distribution Channel: Analyzes direct sales, distributor channels, and online retail, each shaping customer access and engagement.
Test Type: Evaluates confirmatory (lab-based and point-of-care) and screening tests, highlighting the dual demands of precision and mass detection.
Sample Type: Assesses diagnostic relevance of blood, swabs, and urine for optimal sensitivity and patient comfort.
Regional Coverage: Includes detailed segmentation across the Americas (U.S., Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including U.K., Germany, France, Russia, Middle East and African markets), and Asia-Pacific (China, India, Japan, Australia, and Southeast Asian countries).
Company Profiles: Features analytical insights for leading manufacturers such as F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Hologic, Inc., bioMérieux SA, QIAGEN N.V., Thermo Fisher Scientific Inc., Siemens Healthineers AG, Becton, Dickinson and Company, and Cepheid Inc.

Key Takeaways for Senior Decision-Makers

Technology advancement is reshaping diagnostic workflows, with a shift toward decentralized, point-of-care platforms and rapid, sensitive molecular assays.
Integration of diagnostics with digital health and AI platforms is enabling more personalized testing strategies, streamlined reporting, and real-time public health monitoring.
Supply chain resilience and diversified manufacturing are now strategic priorities, as market players respond to tariff-driven cost pressures and regulatory uncertainty.
Cross-sector partnerships across biotech, academia, and government accelerate innovation and commercial translation, impacting speed to market for next-generation solutions.
Smarter segmentation by disease, test type, and region allows stakeholders to align portfolios with emerging geographic demand and clinical priorities.

Tariff Impact: Navigating Supply Chain and Regulatory Changes

Recent U.S. tariffs on imported diagnostic components have compelled organizations to reassess sourcing strategies, balancing imports with local production. This shift has triggered investments in domestic manufacturing and collaboration with policymakers to manage tariff implications. As these adjustments alter cost structures and sourcing flexibility, companies are focused more than ever on transparency in their supply chains and agility in manufacturing footprints.

Methodology & Data Sources

The findings are grounded in direct interviews with industry experts, clinical leaders, and procurement officers, reinforced by thorough reviews of peer-reviewed publications, government reports, and validated industry datasets. A rigorous triangulation process ensures that conclusions and strategic recommendations are empirical and reflect consensus views from across the diagnostics ecosystem.

Why This Report Matters

Enables data-driven decisions by offering a granular view of current market segmentation, innovation priorities, and commercial challenges.
Supports future planning by analyzing disruptive technologies, regional growth opportunities, and the regulatory landscape for sexually transmitted disease diagnostics.
Delivers actionable intelligence to guide investment, partnership, and go-to-market strategies for senior leaders in life sciences and diagnostics.

Conclusion

Senior executives can leverage this report to navigate market complexity, drive innovation, and achieve public health objectives within the sexually transmitted disease diagnostics sector. Stay prepared to capture growth by addressing evolving clinical, regulatory, and operational requirements.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Market Sizing & Forecasting

5. Market Dynamics

5.1. Integration of rapid molecular point-of-care assays for comprehensive STD screening in decentralized settings
5.2. Adoption of high-throughput multiplex PCR platforms to detect multiple sexually transmitted infections concurrently
5.3. Development of AI-driven image analysis tools for automated diagnosis of syphilis and herpes simplex
5.4. Expansion of self-collection sampling kits for at-home chlamydia and gonorrhea testing to improve compliance
5.5. Regulatory approval and market launch of CRISPR-based diagnostic assays for rapid detection of gonococcal antibiotic resistance
5.6. Integration of smartphone connectivity and telehealth platforms for remote STD test result delivery and counseling
5.7. Rising demand for multiplexed serological point-of-care tests addressing emerging HPV and HIV co-infection screening

6. Market Insights

6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Sexually Transmitted Diseases Diagnostics Market, by Technology

8.1. Introduction
8.2. Culture Methods
8.2.1. Bacterial Culture
8.2.2. Cell Culture
8.3. Microscopy
8.3.1. Electron Microscopy
8.3.2. Light Microscopy
8.4. Nucleic Acid Amplification
8.4.1. Loop-Mediated Isothermal Amplification
8.4.2. Pcr
8.4.3. Transcription Mediated Amplification
8.5. Rapid Diagnostics
8.5.1. Lateral Flow Assays
8.5.2. Microfluidic Devices
8.6. Serological Assays
8.6.1. Enzyme-Linked Immunosorbent Assay
8.6.2. Rapid Immunoassay

9. Sexually Transmitted Diseases Diagnostics Market, by Disease

9.1. Introduction
9.2. Chlamydia
9.3. Gonorrhea
9.4. Herpes
9.5. Hiv
9.6. Human Papillomavirus
9.7. Syphilis

10. Sexually Transmitted Diseases Diagnostics Market, by End User

10.1. Introduction
10.2. Clinics
10.3. Diagnostic Laboratories
10.4. Hospitals
10.5. Research Institutes

11. Sexually Transmitted Diseases Diagnostics Market, by Distribution Channel

11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.4. Online Retail

12. Sexually Transmitted Diseases Diagnostics Market, by Test Type

12.1. Introduction
12.2. Confirmatory Tests
12.2.1. Lab Based Tests
12.2.2. Point Of Care Tests
12.3. Screening Tests
12.3.1. Lab Based Tests
12.3.2. Point Of Care Tests

13. Sexually Transmitted Diseases Diagnostics Market, by Sample Type

13.1. Introduction
13.2. Blood
13.3. Swabs
13.4. Urine

14. Americas Sexually Transmitted Diseases Diagnostics Market

14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina

15. Europe, Middle East & Africa Sexually Transmitted Diseases Diagnostics Market

15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland

16. Asia-Pacific Sexually Transmitted Diseases Diagnostics Market

16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan

17. Competitive Landscape

17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. F. Hoffmann-La Roche Ltd
17.3.2. Abbott Laboratories
17.3.3. Danaher Corporation
17.3.4. Hologic, Inc.
17.3.5. bioMérieux SA
17.3.6. QIAGEN N.V.
17.3.7. Thermo Fisher Scientific Inc.
17.3.8. Siemens Healthineers AG
17.3.9. Becton, Dickinson and Company
17.3.10. Cepheid Inc.

18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix

List of Figures

FIGURE 1. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 28. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 29. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 30. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET: RESEARCHARTICLES

List of Tables

TABLE 1. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY BACTERIAL CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY BACTERIAL CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CELL CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY ELECTRON MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY ELECTRON MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY LIGHT MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY LIGHT MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY LOOP-MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY LOOP-MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROFLUIDIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROFLUIDIC DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY GONORRHEA, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY GONORRHEA, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY HERPES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY HERPES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY HIV, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY HIV, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SYPHILIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SYPHILIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY LAB BASED TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY LAB BASED TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY LAB BASED TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY LAB BASED TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SWABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SWABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 167. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, 2018-2024 (USD MILLION)
TABLE 170. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, 2025-2030 (USD MILLION)
TABLE 171. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, 2018-2024 (USD MILLION)
TABLE 172. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, 2025-2030 (USD MILLION)
TABLE 173. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 174. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 175. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 176. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 177. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, 2018-2024 (USD MILLION)
TABLE 178. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, 2025-2030 (USD MILLION)
TABLE 179. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 180. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 181. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 186. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 187. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2024 (USD MILLION)
TABLE 188. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2025-2030 (USD MILLION)
TABLE 189. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, 2018-2024 (USD MILLION)
TABLE 190. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, 2025-2030 (USD MILLION)
TABLE 191. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 192. CANADA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 193. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, 2025-2030 (USD MILLION)
TABLE 197. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, 2018-2024 (USD MILLION)
TABLE 198. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, 2025-2030 (USD MILLION)
TABLE 199. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 200. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 201. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 202. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 203. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, 2018-2024 (USD MILLION)
TABLE 204. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, 2025-2030 (USD MILLION)
TABLE 205. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 206. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 207. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 212. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 213. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2024 (USD MILLION)
TABLE 214. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, 2018-2024 (USD MILLION)
TABLE 216. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, 2025-2030 (USD MILLION)
TABLE 217. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 218. MEXICO SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY RAPID DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL ASSAYS, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CONFIRMATORY TESTS, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SCREENING TESTS, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE, BY CULTURE METHODS, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA SEX

Samples

LOADING...

Companies Mentioned

The companies profiled in this Sexually Transmitted Diseases Diagnostics market report include:

F. Hoffmann-La Roche Ltd
Abbott Laboratories
Danaher Corporation
Hologic, Inc.
bioMérieux SA
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
Becton, Dickinson and Company
Cepheid Inc.

Table Information

Report Attribute	Details
No. of Pages	195
Published	August 2025
Forecast Period	2025 - 2030
Estimated Market Value ( USD ) in 2025	$ 13.53 billion
Forecasted Market Value ( USD ) by 2030	$ 18.17 billion
Compound Annual Growth Rate	6.0%
Regions Covered	Global
No. of Companies Mentioned	11

PURCHASE OPTIONS

Single User License PDF, Excel And Online Access

1 - 5 User License PDF, Excel And Online Access

Site License PDF, Excel And Online Access

Enterprise License PDF, Excel And Online Access

Request Invoice or Quote

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3134EUR$3,545USD£2,706GBP €3483EUR$3,939USD£3,007GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3381EUR$3,824USD£2,919GBP €3757EUR$4,249USD£3,243GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4583EUR$5,183USD£3,956GBP €5092EUR$5,759USD£4,396GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€5545EUR$6,272USD£4,788GBP €6162EUR$6,969USD£5,319GBP

Market Snapshot: Sexually Transmitted Disease Diagnostics Market Overview

Scope & Segmentation

Key Takeaways for Senior Decision-Makers

Tariff Impact: Navigating Supply Chain and Regulatory Changes

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Samples

Companies Mentioned

Table Information

Related Topics

Related Reports

Sexually Transmitted Disease Diagnostics Market by Diagnostic Test Types, Pathogen Types, End-User Types, Sample Types, Technology Types, Product Types - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

Sexually Transmitted Infection Diagnostics Kit Market by Infection Type (Chlamydia, Gonorrhea, HIV), Technology (Flow Cytometry, Immunoassay, Molecular), Sample Type, End User, Distribution Channel, Application - Global Forecast 2025-2030

Molecular Diagnostics For STD Market Size, Share & Trends Analysis Report By Product (Instruments & Services, Consumables), By Application (Chlamydia Testing, Syphilis Testing), By Technology (Laboratory Testing), By Region, And Segment Forecasts, 2025 - 2033

Sexually Transmitted Disease Diagnostics Market Report by Type, Device Type, End User, and Region 2025-2033

Sexually Transmitted Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

About the Sexually Transmitted Disease Test Market